IMMP: Immutep Corp Cash Calculated per Single Share

Symbol and logo of brand Immutep Limited (IMMP)

Immutep Limited develops advanced immunotherapy methods across centers in Europe and Australia. This chart from the GURU.Markets system displays liquid assets per share, where the value of 6.46 reflects the current solvency status. Immutep Limited aims for global expansion of its oncology pipeline through strategic alliances. Currently, the biotech sector is focused on the publication of LAG-3 protein trial results for the treatment of lung and breast cancer.

IMMP immutep.com: Cash Funds per Share in the range 07/04/2022 - 11/20/2026

Analytical breakdowns for Immutep Limited

- price and consensus price forecast:
- market capitalization information:
- cash and cash flow data:
Summary company analysis:Immutep Limited
Flagship merchandise of immutep.com

This indicator reflects the amount of available cash per ordinary share, allowing for an assessment of the company's internal resources to cover obligations without resorting to external borrowing. By analyzing the level of liquid assets per share, an investor can gauge the financial autonomy of Immutep Limited (IMMP), which is critical for sustaining an organic R&D model and conducting large-scale clinical trials in partnership with pharmaceutical behemoths.